| Title | Venue | Year | Impact | Source |
| 3151 | CPNP 2022 Annual Meeting Poster Abstracts | Ment Health Clin | 2022 | | CORD-19 |
| 3152 | COVID-19 AND MYELOMA | Hemasphere | 2022 | | CORD-19 |
| 3153 | B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA | Hemasphere | 2022 | | CORD-19 |
| 3154 | P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL-1 | Hemasphere | 2022 | | CORD-19 |
| 3155 | P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) | Hemasphere | 2022 | | CORD-19 |
| 3156 | P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA | Hemasphere | 2022 | | CORD-19 |
| 3157 | P27: HUMORAL RESPONSE RATE POST MRNA COVID-19 VACCINATION (BNT162B2) IS HIGLY DEPENDENT TO BONE MARROW PLASMACYTOSIS: LONG FOLLOW-UP OF SYMPTOMATIC MULTIPLE MYELOMA PATIENTS | Hemasphere | 2022 | | CORD-19 |
| 3158 | P28: RESPONSE AND VACCINATION STATUS OR LACK OF IMMUNOPARESIS ARE ASSOCIATED WITH BETTER OUTCOME FOLLOWING COVID-19 INFECTION AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE ON 110 PATIENTS | Hemasphere | 2022 | | CORD-19 |
| 3159 | [Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia | Arch Bronconeumol | 2022 | | CORD-19 |
| 3160 | Incorporating mass casualty incidents training in surgical education program | N/A | 2022 | | CORD-19 |
| 3161 | Schutzmaske und Kopfschmerz: Zusätzliche Herausforderung in Zeiten der COVID-19-Pandemie-eine Übersichtsarbeit Newly induced headaches, as well as intensified pre-existing primary headaches following the use of personal protection equipment, has drawn significant attention with the wide use of facemasks in the general population during the coronavirus disease 2019 (COVID‑19) pandemic. Therefore, we present the current state of knowledge regarding facemask-related headache based on three clinical studies, which provides insights to the clinical features and course of this emerging headache entity. Moreover, we summarize preventive and therapeutic recommendations. | N/A | 2022 | | CORD-19 |
| 3162 | Verschwörungstheorien und paranoider Wahn: Lassen sich Aspekte kognitionspsychologischer Modelle zu Entstehung und Aufrechterhaltung von paranoiden Wahnüberzeugungen auf Verschwörungstheorien übertragen? In the present narrative review a set of definitions on conspiracy theories and conspiracy mentality are introduced. In addition, studies on associations between personality variables, symptoms of mental disorders and endorsement of conspiracy theories are discussed. With respect to delusions, the continuum hypothesis is put forward that assumes a continuum between subclinical and clinical symptoms of psychosis. In addition, models on the formation and maintenance of delusions/paranoid delusions are presented that assume an interaction between biological vulnerability, psychological and social factors that leads to the formation and maintenance of paranoid delusions. Cognitive biases and emotional processes mediate the formation of persecutory delusions, e.g. a tendency to jump to conclusions (jumping to conclusions bias) and an external personal attribution style. Regarding cognitive biases and emotional processes, similarities between persons with psychoses and persecutory delusions and persons who endorse conspiracy theories are discussed. Both groups are more prone towards an external locus of control and an external personal attribution stye and were both found to present a jumping to conclusion bias in comparison to nonclinical controls. It is discussed whether these similarities can be further explored using preregistered longitudinal and experimental studies. In addition, the potential of cognitive behavioral therapy for psychosis (CBTp) interventions and their implementation in the prevention and counselling of persons who endorse conspiracy theories and are motivated to reflect on or to change these theories is discussed. | N/A | 2022 | | CORD-19 |
| 3163 | E-waste mining and the transition toward a bio-based economy: The case of lamp phosphor powder ABSTRACT: Replacement of conventional hydrometallurgical and pyrometallurgical process used in E-waste recycling to recover metals can be possible. The metallurgical industry has been considered biohydrometallurgical-based technologies for E-waste recycling. Biorecovery of critical metals from phosphor powder from spent lamps is an example of transition to a bio-based circular economy. E-waste contains economically significant levels of precious, critical metals and rare-earth elements (REE), apart from base metals and other toxic compounds. Recycling and recovery of critical elements from E-waste using a cost-effective technology are now among the top priorities in metallurgy due to the rapid depletion of their natural resources. This paper focuses on the perceptions of recovery of REE from phosphor powder from spent fluorescent lamps regarding a possible transition toward a bio-based economy. An overview of the worldwide E-waste and REE is also demonstrated to reinforce the arguments for the importance of E-waste as a secondary source of some critical metals. Based on the use of bioprocesses, we argue that the replacement of conventional steps used in E-waste recycling by bio-based technological processes can be possible. The bio-recycling of E-waste follows a typical sequence of industrial processes intensely used in classic pyro- and hydrometallurgy with the addition of bio-hydrometallurgical processes such as bioleaching and biosorption. We use the case study of REE biosorption as a new technology based on biological principles to exemplify the potential of urban biomining. The perspective of transition between conventional processes for the recovery of valuable metals for biohydrometallurgy defines which issues related to urban mining can influence the mineral bioeconomy. This assessment is necessary to outline future directions for sustainable recycling development to achieve United Nations Sustainable Development Goals. GRAPHICAL ABSTRACT: | N/A | 2022 | | CORD-19 |
| 3164 | Fluorouracil: Skin reaction: case report | N/A | 2022 | | CORD-19 |
| 3165 | Multiple drugs: New-onset kidney diseases: 5 case reports | N/A | 2022 | | CORD-19 |
| 3166 | Elasomeran/tozinameran: Multiple sclerosis, exacerbation of multiple sclerosis and neuromyelitis optica: 7 case reports | N/A | 2022 | | CORD-19 |
| 3167 | Heparin: Bleeding: case report | N/A | 2022 | | CORD-19 |
| 3168 | Tozinameran: Cold agglutinin disease: case report | N/A | 2022 | | CORD-19 |
| 3169 | Tozinameran: Fasciitis: case report | N/A | 2022 | | CORD-19 |
| 3170 | Multiple drugs: Rhabdomyolysis: case report | N/A | 2022 | | CORD-19 |
| 3171 | AZD-1222: Arterial clot formation: case report | N/A | 2022 | | CORD-19 |
| 3172 | BBIBP-CorV/tozinameran: Subacute thyroiditis: 2 case reports | N/A | 2022 | | CORD-19 |
| 3173 | Dapsone/rituximab: Serum sickness and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3174 | Amiodarone: Torsade de pointes: case report | N/A | 2022 | | CORD-19 |
| 3175 | AZD-1222: Adult-onset Still's disease: case report | N/A | 2022 | | CORD-19 |
| 3176 | Dexchlorpheniramine/enalapril/methylprednisolone: Bradykinergic angioedema and null response: case report | N/A | 2022 | | CORD-19 |
| 3177 | Levodopa/carbidopa: Hallucinations: case report | N/A | 2022 | | CORD-19 |
| 3178 | Dexamethasone/mycophenolate mofetil/prednisolone: Cytomegalovirus reactivation and off label use: case report | N/A | 2022 | | CORD-19 |
| 3179 | Elasomeran: Polymyalgia rheumatica: case report | N/A | 2022 | | CORD-19 |
| 3180 | Wandern während und nach Corona-Segmentierung von Wanderzielgruppen am Beispiel der Sinus-Milieus Especially during the lockdowns in 2020, some regions in Germany reported overcrowded hiking trails and closed parking spaces for hikers, a condition that was previously unknown in the affected regions and for which many places and regions were not properly prepared. Who does actually hike? And can it be determined empirically that people were hiking more or differently in Germany as a result of the pandemic? Have “new” hikers possibly joined the trails, i.e. people who did not hike before the pandemic, but who have now discovered it for themselves and may continue after the pandemic? Are there differences within the group of hikers and how can one segment them for tourism purposes? The article first briefly reflects on traditional target group definitions, and then goes into more detail about the possible deeper insights into the genesis and characteristics of hiking behaviour that permit lifestyle-oriented segmentation. Are “corona hikers” different hikers from the “pre-corona` hikers” and what does this mean for hiking demand and hiking behaviour towards the end of the pandemic? These questions are addressed in the following article. | N/A | 2022 | | CORD-19 |
| 3181 | Dexamethasone: Bone marrow necrosis following off label treatment with dexamethasone: case report | N/A | 2022 | | CORD-19 |
| 3182 | Elasomeran/methylprednisolone: Acute transverse myelitis and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3183 | Multiple drugs: Rhino-orbital-cerebral mucormycosis and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3184 | Ceftriaxone/doxycycline: Mucormycosis and Rhizopus infection: 2 case reports | N/A | 2022 | | CORD-19 |
| 3185 | Elasomeran/histamine receptor antagonists/steroids: Lack of efficacy and urticarial vasculitis: case report | N/A | 2022 | | CORD-19 |
| 3186 | Anakinra/immune globulin/methylprednisolone: Lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3187 | Tozinameran: Immune thrombocytopenia purpura flare: case report | N/A | 2022 | | CORD-19 |
| 3188 | AZD-1222: Fever, swelling at the injection site and Susac syndrome: case report | N/A | 2022 | | CORD-19 |
| 3189 | Sleep quality, valence, energetic arousal and calmness as predictors of device-based measured physical activity during a three-week mHealth intervention: An ecological momentary assessment study within the SMARTFAMILY trial Physical inactivity is known to be a risk factor for several noncommunicable diseases and has a high prevalence in today’s society. Therefore, it is crucial to understand the psychological factors associated with physical activity (PA). Recent developments in the field of ambulatory assessment and technological advances are promising to enhance our understanding of this relationship by analyzing longitudinal data within- and between-persons. These analyses can reveal important factors to design behavior change interventions to enhance PA. Therefore, this study used an ecological momentary assessment during the 3‑week intervention period in the SMARTFAMILY2.0 trial and aimed to investigate whether valence, calmness, energetic arousal, and sleep quality predict daily steps and moderate to vigorous PA. Overall, 49 adults (35–60 years) and 40 children (5–19 years) were included in this analysis and self-rated their mental state within our smartphone application while also wearing a hip-worn accelerometer for 21 consecutive days (996 days included) during the intervention period. Multilevel analyses were conducted to predict daily PA while considering covariables (e.g., child/adult and non-wear time) both within- and between-persons. The results indicated that higher than average ratings of a person’s valence and energetic arousal on one day predicted increased PA while higher than average calmness predicted decreased PA at the same day within this person. Sleep quality and between-person effects of the affective states showed no clear associations to PA. Overall, these results showed that within-person associations of valence, calmness, and energetic arousal should be considered when designing PA interventions for both children and adults. The influence of sleep quality, as well as between-person effects, should be further explored by future studies. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s12662-022-00809-y) contains supplementary material, which is available to all users. | N/A | 2022 | | CORD-19 |
| 3190 | AZD-1222: Flare of Still's disease: case report | N/A | 2022 | | CORD-19 |
| 3191 | Tozinameran: Immune thrombocytopenic purpura: case report | N/A | 2022 | | CORD-19 |
| 3192 | Adalimumab/infliximab: Lower serologic response: 6 case reports | N/A | 2022 | | CORD-19 |
| 3193 | Azd-1222/dexamethasone/prednisolone: Immune thrombocytopenic purpura and hyperglycaemia: 3 case reports | N/A | 2022 | | CORD-19 |
| 3194 | Covid-19-vaccine-pfizer-biontech: Myocarditis: 4 case reports | N/A | 2022 | | CORD-19 |
| 3195 | Ad26.cov2-s: Thrombosis with thrombocytopenia syndrome: case report | N/A | 2022 | | CORD-19 |
| 3196 | Tozinameran: Malaria recrudescence: case report | N/A | 2022 | | CORD-19 |
| 3197 | Mutliple drugs: Hyperkalaemia and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3198 | Dobutamine/epinephrine/vasopressin: Myocardial injury and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 3199 | Heparin/tranexamic-acid: Various toxicities: 4 case reports | N/A | 2022 | | CORD-19 |
| 3200 | AZD-1222: New relapse of multiple sclerosis and neuromyelitis optica: 9 case reports | N/A | 2022 | | CORD-19 |
